Abstract:Objective To study the relationship between the expression of miR-93 and the prognosis of endoscopic submucosal dissection in the treatment of elderly early gastric cancer and analyze its targeted tumor suppressor genes by bioinformatics.Methods The elderly patients with early gastric cancer who underwent endoscopic submucosal dissection from January 2015 to December 2017 were selected, the expression of miR-93, PTEN, TIMP2 were determined in early gastric cancer tissues, postoperative recurrence was followed-up; Meanwhile, the normal gastric mucosa tissues confirmed by pathology at the same time were taken as the control and the expression of miR-93, PTEN, TIMP2 were detected.Results The expression of miR-93 in early gastric cancer tissue was higher than that in normal gastric mucosa tissue, the expression of PTEN and TIMP2 was lower than that in normal gastric mucosa (P < 0.05) and the expression of miR-93 was negatively correlated with the expression of PTEN and TIMP2, the expression of miR-93 in early gastric cancer with T2 stage, low differentiation and undifferentiation, submucosal infiltration, recurrence was higher than that in early gastric cancer with T1 stage, medium differentiation and high differentiation, intramucosal infiltration and non recurrence, the expression of PTEN and TIMP2 was lower than those in early gastric cancer with T1 stage, medium differentiation and high differentiation, intramucosal infiltration and non recurrence (P < 0.05); Submucosal infiltration, increased expression of miR-93, decreased expression of PTEN and TIMP2 were risk factors for postoperative recurrence of early gastric cancer; the unrecurring rate of early gastric cancer with high expression of miR-93 was lower than that with low expression of miR-93; the best cut-off point for miR-93 to predict the recurrence of early gastric cancer was 0.72.Conclusion The expression of miR-93 is a risk factor for the recurrence of early gastric cancer patients after endoscopic submucosal dissection and has a predictive value for the recurrence. Targeting tumor suppressor genes PTEN and TIMP2 is a possible biological role.